GTCbio’s Molecular Diagnostics Conference is to be held this year in Philadelphia, PA on March 7-8, 2011.

Monrovia, CA -- (SBWire) -- 01/20/2011 -- GTCbio is proud to present its Molecular Diagnostics conference to be held this year in Boston, MA on May 27-28, 2010. This conference will generate discussion on the quest for personalized medicine, the progress of companion diagnostics, novel technology and the search for new biomarkers, and the future trends and emerging targets in the field. It also gives insight to challenges and successes in developing diagnostics, as well as the opportunity to discuss potential collaborations with other companies.

The field of Molecular Diagnostics is more than the testing and tools to better diagnose and treat disease; rather, the goal for innovative technologies and discoveries in the diagnostics field is to treat the right patient with the right therapeutic with the right tools. The pharmaceutical industry has identified the need to develop diagnostic tools alongside the development of therapies to improve the usefulness and cost effectiveness of newly discovered drugs. As the healthcare industry makes advances towards personalized medicine, the rules and guidelines continue to change and adapt making product approval challenging.

Come and join the discussion at GTCbio`s Molecular Diagnostics Conference to be held in Philadelphia, PA on March 7-8, 2011. Network with colleagues in academia, industry, and healthcare to share and learn about the latest technologies and novel discoveries in the diagnostics field. Gain insight into the issues and challenges facing the healthcare industry and hear success stories from industry leaders.

Presenting organizations include Merck, Genentech, Illumina, Quest Diagnostics, On-Q-Ity, OncoVista, Caprion Proteomics and other leaders in the diagnostics industry.

For more information, visit http://www.gtcbio.com.